Literature DB >> 7856994

Practice guidelines and malpractice litigation: a two-way street.

A L Hyams1, J A Brandenburg, S R Lipsitz, D W Shapiro, T A Brennan.   

Abstract

OBJECTIVE: To understand how practice guidelines are used in malpractice litigation.
DESIGN: Review of the open and closed malpractice claims of two medical malpractice insurance companies, and a mailed survey of attorneys who litigate malpractice claims.
SETTING: United States. PARTICIPANTS: Two insurance companies and 960 randomly selected malpractice attorneys. MEASUREMENTS: Frequency and nature of the use of practice guidelines in litigation; understanding and frequency of the use of practice guidelines by attorneys in malpractice cases.
RESULTS: 259 claims opened in 1990-1992 at two insurance companies, including all obstetrics and anesthesia claims and a random sample of other claims, were reviewed. Seventeen of these claims involved practice guidelines, which were used as exculpatory evidence (exonerating the defendant physician) in 4 cases and as inculpatory evidence (implicating the defendant physician) in 12 cases. The only physician or patient factors associated with use of a guideline was a longer physician-patient relationship (P = 0.021). Nine hundred and sixty surveys were mailed and 578 were returned (response rate, 60.1%). Attorneys reported that once a suit is initiated, practice guidelines are likely to be used for inculpatory purposes (inculpatory in 54% of cases; exculpatory in 22.7% of cases). However, guidelines that seem to offer exculpatory value induce attorneys not to bring suits. The only attorney factor associated with increased use of guidelines was a practice in which more than 50% of business was in medical malpractice.
CONCLUSIONS: Guidelines are used both by plaintiffs' and defendants' attorneys in malpractice cases. The emphasis in health reform proposals on guidelines as exculpatory evidence should be carefully considered.

Entities:  

Mesh:

Year:  1995        PMID: 7856994     DOI: 10.7326/0003-4819-122-6-199503150-00008

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  13 in total

1.  Legal and political considerations of clinical practice guidelines.

Authors:  B Hurwitz
Journal:  BMJ       Date:  1999-03-06

Review 2.  Impact of clinical practice guidelines on the clinical microbiology laboratory.

Authors:  Peter H Gilligan
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

Review 3.  How does evidence based guidance influence determinations of medical negligence?

Authors:  Brian Hurwitz
Journal:  BMJ       Date:  2004-10-30

4.  Automated evidence-based critiquing of orders for abdominal radiographs: impact on utilization and appropriateness.

Authors:  L H Harpole; R Khorasani; J Fiskio; G J Kuperman; D W Bates
Journal:  J Am Med Inform Assoc       Date:  1997 Nov-Dec       Impact factor: 4.497

5.  Trends in US malpractice payments in dentistry compared to other health professions - dentistry payments increase, others fall.

Authors:  R P Nalliah
Journal:  Br Dent J       Date:  2017-01-13       Impact factor: 1.626

6.  Clinical practice guidelines in the AANS/CNS Section on Tumors: past, present and future directions.

Authors:  Mark E Linskey; Jeffrey J Olson; Laura S Mitchell; Steven N Kalkanis
Journal:  J Neurooncol       Date:  2014-08-01       Impact factor: 4.130

Review 7.  Liability implications of physician-directed care coordination.

Authors:  Mark A Hall; Ralph A Peeples; Richard W Lord
Journal:  Ann Fam Med       Date:  2005 Mar-Apr       Impact factor: 5.166

8.  Clinical guidelines and the law.

Authors:  B Hurwitz
Journal:  BMJ       Date:  1995-12-09

Review 9.  The US Public Health Service "treating tobacco use and dependence clinical practice guidelines" as a legal standard of care.

Authors:  Randy M Torrijos; Stanton A Glantz
Journal:  Tob Control       Date:  2006-12       Impact factor: 7.552

10.  Standards of care in diagnosis and testing for hereditary colon cancer.

Authors:  Patrick M Lynch
Journal:  Fam Cancer       Date:  2007-08-16       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.